US-headquartered biotech firm Cullgen snaps $40m in Series C round

US-headquartered biotech firm Cullgen snaps $40m in Series C round

Visual from Freedigitalphoto.net

Edited by: Joymitra Rai

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter